OrganoTherapeutics GmbH
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2026
- $253.87K
- $253,868under this UEI
- FY2026 obligations
- $253.87K†
- $253,868Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Sep 30, 2026
- SAM.gov registration
- Active
- Registration expiration date Sep 28, 2027
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Sep 24, 2019 (7 years)
- Location
- Esch-sur-Alzette
- Purpose of registration
- All Awards
- Website
- organo-therapeutics.com
† FY2026 obligations (provisional; DoD awards signed after Jul 28, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI KY6GHXV1CLK3. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2026. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2026: $253,868 (provisional)
Total across 1 fiscal year: $253,868
Top awarding agencies
- Department of Health and Human Services$253,868, 100%
Top awarding sub-agencies
- Food and Drug Administration$253,868, 100%
Top NAICS by obligations
Top product and service codes by obligations
- B504Special studies/analysis- chemical/biological$253,868, 100%
Capabilities
NAICS codes
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Contracts
Latest awards and orders
- 75F40126P00334Purchase orderDepartment of Health and Human ServicesFood and Drug AdministrationLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for OrganoTherapeutics GmbH lists a physical address and a separate mailing address, along with 3 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
25-29, rue Henri Koch
Esch-sur-Alzette
LUX
Mailing Address
25-29, rue Henri Koch
Esch-sur-Alzette
LUX
Government Business Contact
Jens Schwamborn
CEO
29 Rue Henri Koch
Esch-sur-Alzette, 4354
LUX
Electronic Business Contact
Jens Schwamborn
CEO
29 Rue Henri Koch
Esch-sur-Alzette, 4354
LUX
Past Performance Contact
Sonia Sabate Soler
Project Manager / Researcher
29 Rue Henri Koch
Esch-sur-Alzette, L-4354
LUX
Additional Details
As of . Source: SAM.gov Entity Registration.
OrganoTherapeutics GmbH has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires September 28, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation